ABBV:NYE-AbbVie Inc (USD)

COMMON STOCK | Drug Manufacturers-General | NYE

Last Closing Price

USD 117.54

Change

+0.55 (+0.47)%

Market Cap

USD 206.63B

Volume

5.46M

Avg Analyst Target

USD 130.25 (+10.81%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenström's macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; AndroGel for males diagnosed with symptomatic low testosterone; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production. The company was incorporated in 2012 and is based in North Chicago, Illinois.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-07-22 )

Largest Industry Peers for Drug Manufacturers-General

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
JNJ Johnson & Johnson

+0.49 (+0.29%)

USD446.33B 29.94 18.08
PFE Pfizer Inc

+0.45 (+1.10%)

USD229.62B 20.78 15.11
LLY Eli Lilly and Company

+1.20 (+0.51%)

USD227.57B 35.52 26.88
NVS Novartis AG

+0.60 (+0.66%)

USD203.14B 26.00 13.73
MRK Merck & Co., Inc

+0.14 (+0.18%)

USD193.42B 27.59 16.74
BMY Bristol-Myers Squibb Company

+0.80 (+1.19%)

USD149.96B 213.75 23.21
GSK GlaxoSmithKline plc

-0.09 (-0.23%)

USD98.92B 13.71 12.87
AGN Allergan plc

N/A

USD63.66B 22.00 28.44

ETFs Containing ABBV

Symbol Name Weight Mer Price(Change) Market Cap
AGGY WisdomTree Trust - Wisdom.. 0.00 % 0.12 %

+0.10 (+0.19%)

USD1.07B
UC97:LSE UBS(Lux)Fund Solutions B.. 0.00 % 0.20 %

N/A

USD0.27B
QDVG:F iShares V Public Limited .. 0.00 % 0.15 %

+0.05 (+0.64%)

USD1.65B
QDVD:F iShares II plc - iShares .. 0.00 % 0.35 %

-0.18 (-0.50%)

USD0.33B
IS3S:F iShares IV Public Limited.. 0.00 % 0.30 %

-0.01 (-0.02%)

USD6.58B
SUSD:LSE SSgA SPDR ETFs Europe I p.. 0.00 % 0.20 %

N/A

USD0.11B
XUHC:LSE Xtrackers (IE) Plc - Xtra.. 0.00 % 0.12 %

+0.52 (+0.98%)

USD0.57B
XSHC:LSE Xtrackers (IE) Public Lim.. 0.00 % 0.12 %

+4.91 (+0.13%)

USD0.57B
XDWH:LSE Xtrackers (IE) Plc - Xtra.. 0.00 % 0.25 %

+0.39 (+0.80%)

USD1.86B
WHEA:LSE SPDR MSCI World Health Ca.. 0.00 % 0.30 %

+0.40 (+0.72%)

USD0.39B
UQLT:LSE UBS (Irl) ETF plc - Facto.. 0.00 % 0.35 %

N/A

USD0.01B
UDVD:LSE SPDR S&P US Dividend Aris.. 0.00 % 0.35 %

-0.57 (-0.84%)

USD2.77B
UC86:LSE UBS(Lux)Fund Solutions B.. 0.00 % 0.18 %

N/A

USD0.32B
SYBR:F SSgA SPDR ETFs Europe I P.. 0.00 % 0.20 %

+0.06 (+0.22%)

USD0.08B
UC85:LSE UBS(Lux)Fund Solutions B.. 0.00 % 0.23 %

+7.66 (+0.43%)

USD0.08B
UC84:LSE UBS ETF - Bloomberg Barcl.. 0.00 % 0.00 %

N/A

USD0.11B
UC82:LSE UBS(Lux)Fund Solutions B.. 0.00 % 0.23 %

+1.55 (+0.11%)

USD0.04B
UC81:LSE UBS ETF - Bloomberg Barcl.. 0.00 % 0.18 %

N/A

USD0.32B
UC76:LSE UBS ETF - Bloomberg Barcl.. 0.00 % 0.18 %

N/A

USD0.11B
SXLV:LSE SPDR S&P U.S. Health Care.. 0.00 % 0.15 %

+0.38 (+1.00%)

USD0.22B
IWVU:LSE iShares Edge MSCI World V.. 0.00 % 0.30 %

+0.02 (+0.33%)

USD0.25B
IWVL:LSE iShares Edge MSCI World V.. 0.00 % 0.30 %

+0.01 (+0.03%)

USD6.60B
IUHC:LSE iShares S&P 500 Health Ca.. 0.00 % 0.15 %

+0.08 (+0.85%)

USD1.67B
IHCU:LSE iShares V Public Limited .. 0.00 % 0.15 %

+3.63 (+0.51%)

USD1.69B
SPYD:F SSgA SPDR ETFs Europe I P.. 0.00 % 0.35 %

-0.51 (-0.89%)

USD3.07B
UEF0:F UBS ETF - Bloomberg Barcl.. 0.00 % 0.23 %

+0.13 (+0.63%)

USD0.36B
DHSG:LSE WisdomTree US Equity Inco.. 0.00 % 0.35 %

N/A

USD5.37M
SYBR:XETRA SSgA SPDR ETFs Europe I P.. 0.00 % 0.20 %

+0.10 (+0.33%)

USD0.08B
XUHC:XETRA Xtrackers (IE) Public Lim.. 0.00 % 0.12 %

+0.45 (+1.01%)

USD0.57B
XDWH:XETRA Xtrackers (IE) Public Lim.. 0.00 % 0.25 %

+0.34 (+0.82%)

USD1.80B
XDEV:XETRA Xtrackers (IE) Plc - Xtra.. 0.00 % 0.25 %

+0.05 (+0.16%)

USD1.00B
WTEU:XETRA WisdomTree Issuer ICAV - .. 0.00 % 0.29 %

-0.06 (-0.35%)

USD0.02B
WTDY:XETRA WisdomTree Issuer ICAV - .. 0.00 % 0.35 %

-0.11 (-0.59%)

USD0.18M
WTD9:XETRA WisdomTree Issuer ICAV - .. 0.00 % 0.29 %

-0.08 (-0.42%)

USD0.04B
VDIV:XETRA VanEck Vectors ETFs N.V... 0.00 % 0.00 %

+0.04 (+0.14%)

USD0.05B
UEF9:XETRA UBS ETF - Bloomberg Barcl.. 0.00 % 0.18 %

+0.08 (+0.51%)

USD0.12B
UEF8:XETRA UBS ETF - Bloomberg Barcl.. 0.00 % 0.23 %

-0.01 (-0.06%)

USD0.51B
UEF0:XETRA UBS(Lux)Fund Solutions B.. 0.00 % 0.23 %

+0.10 (+0.49%)

USD0.36B
SYBN:XETRA SSgA SPDR ETFs Europe I P.. 0.00 % 0.20 %

+0.32 (+0.99%)

USD0.11B
UEF7:F UBS ETF - Bloomberg Barcl.. 0.00 % 0.18 %

-0.02 (-0.17%)

USD0.33B
SPYD:XETRA SSgA SPDR ETFs Europe I P.. 0.00 % 0.35 %

-0.41 (-0.71%)

USD3.07B
QDVG:XETRA iShares V Public Limited .. 0.00 % 0.15 %

+0.08 (+0.98%)

USD1.65B
QDVD:XETRA iShares II plc - iShares .. 0.00 % 0.35 %

-0.03 (-0.07%)

USD0.32B
IS3S:XETRA iShares IV Public Limited.. 0.00 % 0.30 %

+0.05 (+0.15%)

USD6.58B
ZPDH:F SSgA SPDR ETFs Europe II .. 0.00 % 0.15 %

+0.14 (+0.44%)

USD0.22B
XDWH:F Xtrackers (IE) Public Lim.. 0.00 % 0.25 %

+0.14 (+0.33%)

USD1.10B
WTEU:F WisdomTree US Equity Inco.. 0.00 % 0.29 %

-0.04 (-0.20%)

USD0.01B
WTDY:F WisdomTree Issuer ICAV - .. 0.00 % 0.35 %

-0.07 (-0.38%)

USD0.18M
WTD9:F WisdomTree US Equity Inco.. 0.00 % 0.29 %

-0.04 (-0.22%)

USD0.04B
UEF9:F UBS ETF - Bloomberg Barcl.. 0.00 % 0.18 %

+0.03 (+0.22%)

USD0.12B
DHSP:LSE WisdomTree Issuer ICAV - .. 0.00 % 0.29 %

N/A

USD0.04B
DHSD:LSE WisdomTree US Equity Inco.. 0.00 % 0.29 %

N/A

USD0.02B
BSCP Invesco BulletShares 2025.. 0.00 % 0.10 %

+0.03 (+0.11%)

USD1.02B
IXJ iShares Global Healthcare.. 0.00 % 0.46 %

+0.30 (+0.35%)

USD3.10B
RXL ProShares Trust - ProShar.. 0.00 % 0.95 %

+1.24 (+1.27%)

USD0.22B
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

-0.17 (-1.18%)

USD1.19M
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

-0.17 (-1.18%)

USD1.19M
PWV Invesco Exchange-Traded F.. 0.00 % 0.56 %

-0.26 (-0.59%)

USD0.73B
PPH VanEck Vectors Pharmaceut.. 0.00 % 0.35 %

+0.19 (+0.25%)

USD0.23B
PJP Invesco Dynamic Pharmaceu.. 0.00 % 0.56 %

+0.03 (+0.04%)

USD0.37B
LQD iShares iBoxx $ Investmen.. 0.00 % 0.14 %

+0.56 (+0.41%)

USD40.23B
LNGR Global X Aging Population.. 0.00 % 0.50 %

N/A

USD0.04B
JHMH John Hancock Multifactor .. 0.00 % 0.40 %

+0.32 (+0.66%)

USD0.05B
IYH iShares U.S. Healthcare E.. 0.00 % 0.43 %

+1.94 (+0.69%)

USD2.66B
IBDQ iShares iBonds Dec 2025 T.. 0.00 % 0.10 %

+0.04 (+0.15%)

USD1.13B
SDYL UBS ETRACS Monthly Pay 2x.. 0.00 % 0.30 %

N/A

USD9.68M
IBDN iShares Trust - iShares i.. 0.00 % 0.10 %

N/A

USD1.57B
IBDL iShares iBonds Dec 2020 T.. 0.00 % 0.10 %

N/A

USD0.95B
FHLC Fidelity MSCI Health Care.. 0.00 % 0.08 %

+0.29 (+0.45%)

USD2.70B
FDRR Fidelity Dividend ETF for.. 0.00 % 0.29 %

-0.15 (-0.35%)

USD0.47B
FDL First Trust Morningstar D.. 0.00 % 0.45 %

-0.03 (-0.09%)

USD1.64B
ESGW Columbia Sustainable Glob.. 0.00 % 0.40 %

N/A

USD0.01B
DHS WisdomTree U.S. High Divi.. 0.00 % 0.38 %

-0.16 (-0.20%)

USD0.81B
DEW WisdomTree Global High Di.. 0.00 % 0.58 %

-0.08 (-0.16%)

USD0.08B
CURE Direxion Daily Healthcare.. 0.00 % 1.01 %

+2.35 (+2.10%)

USD0.17B
CUD:CA iShares US Dividend Growe.. 0.00 % 0.66 %

-0.39 (-0.77%)

USD0.37B
SDY SPDR S&P Dividend ETF 0.00 % 0.35 %

-0.90 (-0.74%)

USD19.67B
VHT Vanguard Health Care Inde.. 0.00 % 0.10 %

+1.20 (+0.48%)

USD17.94B
DHSA:LSE WisdomTree US Equity Inco.. 0.00 % 0.29 %

N/A

USD0.04B
FHI:CA CI Health Care Giants Cov.. 0.00 % 0.72 %

+0.04 (+0.34%)

USD0.09B
DHS:LSE WisdomTree Issuer ICAV - .. 0.00 % 0.29 %

-14.30 (-0.92%)

USD0.02B
BSUS:LSE UBS (Lux) Fund Solutions .. 0.00 % 0.25 %

+3.70 (+0.32%)

USD0.10B
PHE-B:CA Purpose Tactical Hedged E.. 0.00 % 0.97 %

N/A

N/A
FHI-B:CA CI Health Care Giants Cov.. 0.00 % 0.74 %

N/A

N/A
ZWH-U:CA BMO US High Dividend Cove.. 0.00 % 0.72 %

+0.16 (+0.67%)

N/A
LS:CA Middlefield Healthcare &a.. 0.00 % 1.31 %

+0.07 (+0.61%)

USD0.09B
AWTM Aware Ultra-Short Duratio.. 0.00 % 0.25 %

N/A

USD0.16B
DSTL Distillate U.S. Fundament.. 0.00 % 0.39 %

-0.04 (-0.09%)

USD0.36B
SDGA Impact Shares Sustainable.. 0.00 % 0.75 %

-0.04 (-0.14%)

USD5.46M
IGIB iShares 5-10 Year Investm.. 0.00 % 0.06 %

+0.12 (+0.20%)

USD11.87B
QUIG:CA Mackenzie US Investment G.. 0.00 % 0.17 %

N/A

USD0.41B
WBIL WBI BullBear Quality 3000.. 0.00 % 1.23 %

+0.04 (+0.14%)

USD0.05B
VSMV VictoryShares US Multi-Fa.. 0.00 % 0.35 %

+0.03 (+0.07%)

USD0.16B
RNDV First Trust US Equity Div.. 0.00 % 0.50 %

+0.09 (+0.31%)

USD0.01B
FTXH First Trust Nasdaq Pharma.. 0.00 % 0.60 %

+0.16 (+0.61%)

USD0.02B
NUBD Nuveen ESG U.S. Aggregate.. 0.00 % 0.20 %

+0.07 (+0.27%)

USD0.26B
WBIY WBI Power Factor High Div.. 0.00 % 0.70 %

-0.24 (-0.90%)

USD0.06B
LIFE:CA Evolve Global Healthcare .. 0.00 % 0.45 %

+0.03 (+0.13%)

USD0.01B
CAPS:CA Evolve Active US Core Equ.. 0.00 % 0.70 %

N/A

USD3.62M
HID:CA WisdomTree U.S. High Divi.. 0.00 % 0.40 %

N/A

USD4.31M
ZWH:CA BMO US High Dividend Cove.. 0.00 % 0.71 %

-0.01 (-0.02%)

USD0.86B
XLV Health Care Select Sector.. 0.00 % 0.12 %

+0.95 (+0.74%)

USD27.88B
XHC:CA iShares Global Healthcare.. 0.00 % 0.65 %

+0.22 (+0.34%)

USD0.50B
ZPDH:XETRA SSgA SPDR ETFs Europe II .. 0.00 % 0.15 %

+0.34 (+1.07%)

USD0.22B

Market Performance

  Market Performance vs.
Industry/Classification (Drug Manufacturers-General)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.70% 75% C 52% F
Dividend Return 3.64% 100% A+ 82% B-
Total Return 13.34% 75% C 57% F
Trailing 12 Months  
Capital Gain 19.90% 88% B+ 41% F
Dividend Return 5.18% 88% B+ 69% D+
Total Return 25.08% 88% B+ 43% F
Trailing 5 Years  
Capital Gain 84.20% 88% B+ 76% C
Dividend Return 28.90% 100% A+ 83% B
Total Return 113.10% 88% B+ 80% B-
Average Annual (5 Year Horizon)  
Capital Gain 16.29% 88% B+ 78% C+
Dividend Return 4.39% 88% B+ 80% B-
Total Return 20.68% 88% B+ 81% B-
Risk Return Profile  
Volatility (Standard Deviation) 29.80% 13% F 36% F
Risk Adjusted Return 69.40% 75% C 77% C+
Market Capitalization 206.63B 63% D 99% A+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Drug Manufacturers-General)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 40.16 25% F 19% F
Price/Book Ratio 15.14 25% F 7% F
Price / Cash Flow Ratio 11.75 75% C 39% F
EV/EBITDA 19.12 38% F 32% F
Management Effectiveness  
Return on Equity 163.56% 100% A+ 98% A+
Return on Invested Capital 17.48% 75% C 89% B+
Return on Assets 8.48% 75% C 91% A-
Debt to Equity Ratio 593.10% 13% F 4% F
Technical Ratios  
Short Ratio 2.42 50% F 43% F
Short Percent 0.79% 38% F 81% B-
Beta 0.80 13% F 70% C-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters then its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.